| Cell line name |
KML1 |
|---|
| Accession |
CVCL_4J73 |
|---|
| Resource Identification Initiative |
To cite this cell line use: KML1 (RRID:CVCL_4J73) |
|---|
| Comments |
Doubling time: 24 hours (PubMed=3091508).
Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. |
|---|
| Disease |
Mouse lymphoma (NCIt: C21602) |
|---|
| Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090)
Breed/subspecies: MRL/lpr. |
|---|
| Hierarchy |
Children:
|
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
4M |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=3091508; DOI=10.1159/000234114
Kanai Y., Katagiri T., Mori S., Kubota T.
An established MRL/Mp-lpr/lpr cell line with null cell properties produces a B cell differentiation factor(s) that promotes anti-single-stranded DNA antibody production in MRL spleen cell culture.
Int. Arch. Allergy Appl. Immunol. 81:92-94(1986) DOI=10.1159/000415049
Kanai Y., Katagiri T., Mori S., Kanai Y.
Establishment and function of an MRL/Mp-lpr/lpr lymphoma line with null cell properties: its roles for anti-DNA antibody production in vitro.
(In book chapter) Cellular, molecular, genetic approaches to immunodiagnosis and immunotherapy. 8th International conference on labeled antibodies, Tokyo, November 1985; Kano K., Mori S., Sugisaki T., Torisu M. (eds.); pp.283-288; Karger; Basel; Switzerland (1988) Patent=US5132222
Kanai Y., Awaya A.
Established cell line, KML1-7, which produces B-cell differentiation factor (BCDF).
Patent number US5132222, 21-Jul-1992 |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54900122
|
|---|
| Entry history |
|---|
| Entry creation | 22-Sep-2015 |
|---|
| Last entry update | 10-Sep-2024 |
|---|
| Version number | 6 |
|---|
